Althea recorded its highest ever monthly revenue in November 2020.
Althea’s Australian operations netted $737,121 of unaudited revenue in November and the company is seeing a strong rebound in sales in Victoria following the state’s recent COVID-19 lockdown.
Althea’s UK operations recorded 48% month-on-month growth and unaudited revenue of $110,378 in November.
Althea CEO Josh Fegan, who recently relocated to London to oversee the growth of the Althea brand in the UK and European Union, said: “With our market access strategy starting to resonate with UK prescribers and regulatory headwinds well and truly behind us, it is great to see our many months of hard work beginning to pay off.
“Our established Australian business continues to perform strongly, and we are looking forward to entering 2021 with fantastic momentum.”